ArticleVirology journal2025
Genetic variability and phylogenetic analysis of the long control region in human papillomavirus types 18 and 51 from central China.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundHigh-risk human papillomavirus (HR-HPV) is the main pathogenic factor of cervical cancer. Both HPV-18 and HPV-51 belong to HR-HPV.
methodsClinical samples were collected and processed to isolate single-positive HPV-18 and HPV-51 specimens. These specimens were then subjected to amplification of long control region (LCR) fragments and sequencing. Finally, a set of bioinformatic analyses was performed, including the evaluation of sequence variations, construction of phylogenetic trees, and prediction of transcription factor binding sites.
resultsA total of 43 HPV-18 LCRs were successfully sequenced, yielding 17 single nucleotide polymorphisms (SNPs), while sequencing of 56 HPV-51 LCRs revealed 42 SNPs. Phylogenetic analysis demonstrated that HPV-18 variants clustered exclusively within lineage A, whereas HPV-51 variants were predominantly grouped in the same lineage. JASPAR predictions indicated potential functional consequences, with 11 HPV-18 mutation sites and 12 HPV-51 mutation sites possibly disrupting transcription factor binding sites.
conclusionThis study describes the genetic variations of the LCR of HPV-18 and HPV-51 in central China, which may disrupt binding sites of transcription factors. It provides important insights into the evolutionary characteristics and potential carcinogenic mechanisms of HPV in Central China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.